Improved Down syndrome blood test leads to ethics debate

11/28/2011 | Bangor Daily News (Maine) (free registration)

The new method for detecting Down syndrome, called MaterniT21, isolates the fetal DNA in a mother's bloodstream and can determine whether an extra chromosome is present. The test is accurate and safer than other techniques, causing some to worry that more pregnancies of fetuses with Down syndrome will end in abortion. Some families and advocates fear a decline in people with Down syndrome will result in a decrease in resources for their community.

View Full Article in:

Bangor Daily News (Maine) (free registration)

Published in Brief:

SmartBrief Job Listings for Education

Job Title Company Location
Program Officer, Teacher Development
Knowles Science Teaching Foundation
Moorestown, NJ
Production Manager, Education and Leadership
Asia Society
New York, NY
CONTRACT - Education Consultants
Confidential
East Coast, Phoenix, Los Angeles, SL_Multiple Locations
Inside Sales Representative
Apperson, Inc.
Multiple Locations, SL_Multiple Locations
Product Marketing Manager
Apperson, Inc.
Charlotte, NC